Oral absorption of pivampicillin and ampicillin in young children: cross-over study using equimolar doses of a suspension. 1977

L Pedersen-Bjergaard, and K E Petersen

In a cross-over study, the oral absorption following equimolar doses of ampicillin corresponding to 16.7 mg/kg administrered as pivampicillin ('Pondocillin') suspension and ampicillin ('Doktacillin') suspension respectively, was investigated in 11 children aged from 8 months to 4.5 years. Pivampicillin produced a mean peak serum concentration of 10.7 microgram ampicillin/ml compared with 5.8 microgram/ml after ampicillin. The mean area under the serum concentration-time curves was 29.2 microgram/ml-h after pivampicillin and 16.7 microgram/ml-h after ampicillin, reflecting the superior bioavailability of the ester form. In 4 of the children aged between 8 and 12 months, the serum levels after pivampicillin were consistenly lower than those recorded in the remaining 7 children beyound the age of 1 year. The mechanism and therapeutic implications of this finding require further study.

UI MeSH Term Description Entries
D007223 Infant A child between 1 and 23 months of age. Infants
D007408 Intestinal Absorption Uptake of substances through the lining of the INTESTINES. Absorption, Intestinal
D008297 Male Males
D010917 Pivampicillin Pivalate ester analog of AMPICILLIN. Ampicillin Pivaloyl Ester,Berocillin,Pivamiser,Pivampicillin Hydrochloride,Pivampicillin Monohydrochloride,Pondocillin,Ester, Ampicillin Pivaloyl,Hydrochloride, Pivampicillin,Monohydrochloride, Pivampicillin
D002675 Child, Preschool A child between the ages of 2 and 5. Children, Preschool,Preschool Child,Preschool Children
D002986 Clinical Trials as Topic Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries. Clinical Trial as Topic
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000284 Administration, Oral The giving of drugs, chemicals, or other substances by mouth. Drug Administration, Oral,Administration, Oral Drug,Oral Administration,Oral Drug Administration,Administrations, Oral,Administrations, Oral Drug,Drug Administrations, Oral,Oral Administrations,Oral Drug Administrations
D000667 Ampicillin Semi-synthetic derivative of penicillin that functions as an orally active broad-spectrum antibiotic. Penicillin, Aminobenzyl,Amcill,Aminobenzylpenicillin,Ampicillin Sodium,Ampicillin Trihydrate,Antibiotic KS-R1,Omnipen,Pentrexyl,Polycillin,Ukapen,Aminobenzyl Penicillin,Antibiotic KS R1,KS-R1, Antibiotic,Sodium, Ampicillin,Trihydrate, Ampicillin

Related Publications

L Pedersen-Bjergaard, and K E Petersen
July 1981, Acta pharmacologica et toxicologica,
L Pedersen-Bjergaard, and K E Petersen
December 1974, South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde,
L Pedersen-Bjergaard, and K E Petersen
January 1972, Scandinavian journal of infectious diseases,
L Pedersen-Bjergaard, and K E Petersen
July 1989, Drug and therapeutics bulletin,
L Pedersen-Bjergaard, and K E Petersen
November 1974, Antimicrobial agents and chemotherapy,
L Pedersen-Bjergaard, and K E Petersen
February 1975, MMW, Munchener medizinische Wochenschrift,
L Pedersen-Bjergaard, and K E Petersen
January 1977, The Journal of international medical research,
L Pedersen-Bjergaard, and K E Petersen
January 1974, Scandinavian journal of respiratory diseases,
L Pedersen-Bjergaard, and K E Petersen
January 1974, European journal of clinical pharmacology,
L Pedersen-Bjergaard, and K E Petersen
September 1977, Ugeskrift for laeger,
Copied contents to your clipboard!